By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Prothena Corporation plc 

25-28 North Wall Quay

  Dublin  1  Ireland
Phone: 353-1-902-3519 Fax: 353-1-902-3510



Company News
Clinical Results Presented From Prothena (PRTA)’s Phase Ib Study Of PRX002/RG7935 Demonstrating Robust Antibody CNS Penetration And Significant Reduction Of Free Serum Alpha-Synuclein In Patients With Parkinson’s Disease 4/3/2017 7:42:54 AM
Prothena (PRTA) Announces President And CEO Dr. Dale B. Schenk To Take Medical Leave 9/27/2016 7:24:49 AM
Prothena (PRTA) Presents First Clinical Data for PRX003 for the Treatment of Inflammatory Diseases 6/10/2016 12:25:46 PM
Prothena (PRTA) Announces Appointment Of Chief Commercial Officer 2/25/2016 10:02:48 AM
Three Companies That Are Just as Great as Gilead (GILD) 2/4/2016 6:37:02 AM
Prothena (PRTA) To Participate In Oppenheimer And RBC Capital Markets Healthcare Investor Conferences 12/2/2015 9:37:18 AM
Prothena (PRTA) To Present At The 2015 Credit Suisse Healthcare Conference On November 10 11/4/2015 2:34:35 PM
Prothena (PRTA) Reports Third Quarter 2015 Financial Results And Provides R&D Update 10/23/2015 10:05:08 AM
Prothena (PRTA) To Initiate PRONTO, A Global Trial Of NEOD001 In Patients With AL Amyloidosis With Primary Endpoint Of Cardiac Response 10/15/2015 2:25:12 PM
Prothena (PRTA) To Present At Ladenburg Thalmann 2015 Healthcare Conference On September 29 9/23/2015 8:01:57 AM